09:50 AM EST - Lattice Biologics Ltd. : Announced today that -- subject to approval by the TSX Venture Exchange -- the Company will increase the amount of the planned conversion of debt (announced on August 10) into equity of Lattice Biologics from $474,570 U.S. to $667,252 U.S. Lattice Biologics Ltd.
shares V.LBL are trading up $0.035 at $0.25.
